Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    April 2019
  1. LUM E, Jimenez G, Huang Z, Thai L, et al
    Decision Support and Alerts of Apps for Self-management of Blood Glucose for Type 2 Diabetes.
    JAMA. 2019;321:1530-1532.
    PubMed     Text format    


  2. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    PubMed     Text format    


  3. RODRIGUEZ-GUTIERREZ R, McCoy RG
    Measuring What Matters in Diabetes.
    JAMA. 2019 Apr 15. pii: 2730954. doi: 10.1001/jama.2019.4310.
    PubMed     Text format    


    March 2019
  4. ROSENSTOCK J, Allison D, Birkenfeld AL, Blicher TM, et al
    Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
    JAMA. 2019 Mar 23. pii: 2729339. doi: 10.1001/jama.2019.2942.
    PubMed     Text format     Abstract available


  5. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    PubMed     Text format    


  6. GLASSMAN AR
    Errors in Analysis of Mean Deviations in Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1007-1008.
    PubMed     Text format    



  7. Errors in Analysis of Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1008.
    PubMed     Text format    


  8. BALDUCCI S, D'Errico V, Haxhi J, Sacchetti M, et al
    Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.
    JAMA. 2019;321:880-890.
    PubMed     Text format     Abstract available


    February 2019
  9. LOWE WL JR, Scholtens DM, Metzger BE
    Gestational Diabetes and Childhood Obesity-Reply.
    JAMA. 2019;321:708-709.
    PubMed     Text format    


  10. BRADSHAW JM, Ensor SJA, Lorenz HAL
    Gestational Diabetes and Childhood Obesity.
    JAMA. 2019;321:708.
    PubMed     Text format    


  11. SKIPPER N, Gaulke A, Sildorf SM, Eriksen TM, et al
    Association of Type 1 Diabetes With Standardized Test Scores of Danish Schoolchildren.
    JAMA. 2019;321:484-492.
    PubMed     Text format     Abstract available


    January 2019
  12. LUO J, Khan NF, Manetti T, Rose J, et al
    Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    JAMA. 2019;321:374-384.
    PubMed     Text format     Abstract available


  13. LIPSKA KJ
    Insulin Analogues for Type 2 Diabetes.
    JAMA. 2019;321:350-351.
    PubMed     Text format    


  14. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    PubMed     Text format     Abstract available


  15. NAGPAL SJS, Chari ST
    Immunoglobulin G4 Levels.
    JAMA. 2019;321:202-203.
    PubMed     Text format    


  16. SIMHA V, Shah P
    Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    JAMA. 2019 Jan 7. pii: 2720429. doi: 10.1001/jama.2018.20922.
    PubMed     Text format    


  17. GRENNAN D
    Diabetic Foot Ulcers.
    JAMA. 2019;321:114.
    PubMed     Text format    


    December 2018
  18. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Text format     Abstract available


  19. SLOMSKI A
    Dual Receptor Agonist for Type 2 Diabetes.
    JAMA. 2018;320:2521.
    PubMed     Text format    


    November 2018
  20. TUNG EL, Davis AM, Laiteerapong N
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply.
    JAMA. 2018;320:1937-1938.
    PubMed     Text format    


  21. KANSAGARA D, Qaseem A, Wilt TJ
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes.
    JAMA. 2018;320:1937.
    PubMed     Text format    


  22. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    PubMed     Text format     Abstract available


    October 2018
  23. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    PubMed     Text format    


  24. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    PubMed     Text format     Abstract available


  25. KING WC, Hinerman AS, Belle SH, Wahed AS, et al
    Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.
    JAMA. 2018;320:1560-1569.
    PubMed     Text format     Abstract available


  26. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed     Text format    


  27. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed     Text format    


  28. OSPINA NS, Young WF Jr, Ghayee HK
    Diagnostic Testing for Elevated Cortisol in the Setting of an Adrenal Mass.
    JAMA. 2018;320:1373-1374.
    PubMed     Text format    


    September 2018
  29. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:1163-1171.
    PubMed     Text format     Abstract available


  30. LEBLANC ES, Patnode CD, Webber EM, Redmond N, et al
    Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;320:1172-1191.
    PubMed     Text format     Abstract available


  31. JIN J
    Behavioral Interventions for Weight Loss.
    JAMA. 2018;320:1210.
    PubMed     Text format    


  32. LOWE WL JR, Scholtens DM, Lowe LP, Kuang A, et al
    Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity.
    JAMA. 2018;320:1005-1016.
    PubMed     Text format     Abstract available


    August 2018
  33. ABBASI J
    Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
    JAMA. 2018;320:539.
    PubMed     Text format    


    June 2018
  34. RUBIN R
    Phone Apps for Patients With Diabetes.
    JAMA. 2018;319:2469.
    PubMed     Text format    


  35. XIANG AH, Wang X, Martinez MP, Page K, et al
    Maternal Type 1 Diabetes and Risk of Autism in Offspring.
    JAMA. 2018 Jun 23. pii: 2685775. doi: 10.1001/jama.2018.7614.
    PubMed     Text format    


  36. LIPSKA KJ, Parker MM, Moffet HH, Huang ES, et al
    Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    JAMA. 2018 Jun 23. pii: 2685850. doi: 10.1001/jama.2018.7993.
    PubMed     Text format     Abstract available


  37. CROWLEY MJ, Maciejewski ML
    Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
    JAMA. 2018 Jun 23. pii: 2685849. doi: 10.1001/jama.2018.8033.
    PubMed     Text format    



  38. Ertugliflozin for Type 2 Diabetes.
    JAMA. 2018;319:2434-2435.
    PubMed     Text format    


  39. TUNG EL, Davis AM, Laiteerapong N
    Glycemic Control in Nonpregnant Adults With Type 2 Diabetes.
    JAMA. 2018;319:2430-2431.
    PubMed     Text format    


    May 2018
  40. ABBASI J
    For Patients With Type 2 Diabetes, What's the Best Target Hemoglobin A1C?
    JAMA. 2018 May 30. pii: 2683543. doi: 10.1001/jama.2018.5420.
    PubMed     Text format    


  41. HEWITT DB, Barnard C, Bilimoria KY
    Improving Emergency Insulin Administration-Reply.
    JAMA. 2018;319:1937-1938.
    PubMed     Text format    


  42. SENAT MV, Affres H, Letourneau A, Coustols-Valat M, et al
    Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2018;319:1773-1780.
    PubMed     Text format     Abstract available


  43. COUSTAN DR, Barbour L
    Insulin vs Glyburide for Gestational Diabetes.
    JAMA. 2018;319:1769-1770.
    PubMed     Text format    


    April 2018
  44. ZHENG SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1580-1591.
    PubMed     Text format     Abstract available


  45. SHAPIRO AR
    Continuous Glucose Monitors for Insulin Dosing-Reply.
    JAMA. 2018;319:1384.
    PubMed     Text format    


  46. BECK RW
    Continuous Glucose Monitors for Insulin Dosing.
    JAMA. 2018;319:1383.
    PubMed     Text format    


    March 2018
  47. COGSWELL ME, Loria CM, Terry AL, Zhao L, et al
    Estimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults.
    JAMA. 2018;319:1209-1220.
    PubMed     Text format     Abstract available


  48. DE BOER IH, Bakris G, Cannon CP
    Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.
    JAMA. 2018 Mar 15. pii: 2675563. doi: 10.1001/jama.2018.0642.
    PubMed     Text format    


    February 2018
  49. MOORE A, Derry S, Wiffen P
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.
    PubMed     Text format     Abstract available


  50. VOELKER R
    Diabetic Foot Ulcers Heal With Shock Wave Therapy.
    JAMA. 2018;319:649.
    PubMed     Text format    


  51. SCHILLINGER D, Huey N
    Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes.
    JAMA. 2018 Feb 14. pii: 2672777. doi: 10.1001/jama.2018.0986.
    PubMed     Text format    


  52. KARGES B, Binder E, Rosenbauer J
    Complications With Insulin Pump Therapy vs Insulin Injection Therapy-Reply.
    JAMA. 2018;319:503-504.
    PubMed     Text format    


    January 2018
  53. IKRAMUDDIN S, Korner J, Lee WJ, Thomas AJ, et al
    Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    JAMA. 2018;319:266-278.
    PubMed     Text format     Abstract available


  54. ABBASI J
    Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.
    JAMA. 2018;319:215-217.
    PubMed     Text format    


  55. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Text format     Abstract available


  56. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Text format     Abstract available


  57. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed     Text format    


  58. KNIP M, Akerblom HK, Al Taji E, Becker D, et al
    Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    JAMA. 2018;319:38-48.
    PubMed     Text format     Abstract available


  59. HAMPTON T
    Smart Artificial Beta Cells May Help Treat Diabetes.
    JAMA. 2018;319:11-12.
    PubMed     Text format    


    December 2017
  60. BANCKS MP, Kershaw K, Carson AP, Gordon-Larsen P, et al
    Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    JAMA. 2017;318:2457-2465.
    PubMed     Text format     Abstract available


  61. RIED-LARSEN M, Johansen MY, Pedersen BK
    Intensive Lifestyle Intervention for Type 2 Diabetes-Reply.
    JAMA. 2017;318:2494-2495.
    PubMed     Text format    


  62. GIUGLIANO D, Maiorino MI, Esposito K
    Intensive Lifestyle Intervention for Type 2 Diabetes.
    JAMA. 2017;318:2494.
    PubMed     Text format    


  63. TING DSW, Cheung CY, Lim G, Tan GSW, et al
    Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
    JAMA. 2017;318:2211-2223.
    PubMed     Text format     Abstract available


    November 2017
  64. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  65. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  66. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


  67. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed     Text format    


  68. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed     Text format    


  69. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed     Text format    


    October 2017
  70. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed     Text format    


  71. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed     Text format    


  72. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed     Text format    


  73. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Text format     Abstract available


  74. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Text format     Abstract available


  75. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Text format     Abstract available


  76. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed     Text format    


    August 2017
  77. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: